Bridgeway National (BDGY) 10-Q 14 Jun 21 2021 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2021	Jun. 14, 2021
Cover [Abstract]
Entity Registrant Name	BRIDGEWAY NATIONAL CORP.
Entity Central Index Key	0001567771
Document Type	10-Q
Document Period End Date	Mar. 31, 2021
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business Flag	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		2,410,229
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2021

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current Assets:
Cash	$ 90,183	$ 1,915
Total Current Assets	90,183	1,915
Property and equipment, net	76,936	79,273
Rights-of-use assets	682,702	722,088
Total Assets	849,821	803,276
Current Liabilities:
Accounts payable	217,098	217,098
Accrued expenses	541,250	417,960
Accrued interest expenses on convertible notes payable	156,880	94,727
Dividend payable	64,352	54,366
Due to related party	69,903	81,277
Convertible notes payable, net of unamortized discount $96,166 (2020 - $184,388)	1,222,834	1,086,612
Derivative liability - notes and warrants	1,588,272	1,717,337
Right of use liabilities - operating leases, current	130,644	115,547
Total Current Liabilities	3,991,233	3,784,924
Long-term Notes payable	150,000
Right of use liabilities - operating leases, long term	612,362	657,457
Total Liabilities	4,753,595	4,442,381
Stockholders' Deficiency:
Additional paid-in capital	7,378,923	7,388,909
Accumulated deficit	(11,285,233)	(11,030,550)
Total Stockholders' deficiency	(3,903,774)	(3,639,105)
Total Liabilities and Stockholders' Deficiency	849,821	803,276
Series A Preferred Stock [Member]
Stockholders' Deficiency:
Preferred Stock, value	1	1
Series B Preferred Stock [Member]
Stockholders' Deficiency:
Preferred Stock, value	125	125
Class B Common Stock [Member]
Stockholders' Deficiency:
Common Stock, value
Class A Common Stock [Member]
Stockholders' Deficiency:
Common Stock, value	$ 2,410	$ 2,410

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Convertible notes payable, unamortized discount	$ 96,166	$ 184,388
Series A Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	62,374,819	62,374,819
Preferred stock, shares issued	1,000	1,000
Preferred stock, shares outstanding	1,000	1,000
Series B Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	125,181	125,181
Preferred stock, shares issued	125,001	125,001
Preferred stock, shares outstanding	125,001	125,001
Class B Common Stock [Member]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	18,750,000	18,750,000
Common stock, shares issued
Common stock, shares outstanding
Class A Common Stock [Member]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	168,750,000	168,750,000
Common stock, shares issued	2,410,229	2,410,229
Common stock, shares outstanding	2,410,229	2,410,229

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Operating expenses:
Professional fees	$ 10,670	$ 32,210
General and administrative	160,099	176,422
Amortization expense	41,723	1,958
Total operating expenses	212,492	210,590
Loss from operations	(212,492)	(210,590)
Other income (expenses)
Change in fair value of derivative liabilities	129,065	37,994
Loss on derivative liabilities		(1,739,698)
Interest expense	(171,256)	(99,330)
Total other income (expenses)	(42,191)	(1,801,034)
Loss from continuing operations before income tax provision	(254,683)	(2,011,624)
Income tax provision
Loss before income tax provision	(254,683)	(2,011,624)
Net loss	(254,683)	(2,011,624)
Series B preferred stock dividend	(9,986)	(9,986)
Net loss attributable to common stockholders	$ (264,669)	$ (2,021,610)
Net loss per Common share:
- Basic and Diluted	$ (0.11)	$ (0.84)
Weighted average commons shares Outstanding:
- Basic and Diluted	2,410,229	2,410,229

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Deficiency (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Series A Preferred Stock [Member]
Balance	$ 1	$ 1
Balance, shares	1,000	1,000
Preferred stock issued as compensation for financing
Preferred stock issued as compensation for financing, shares
Series B Preferred stock dividend
Deemed distributions to CEO
Net Loss
Balance	$ 1	$ 1
Balance, shares	1,000	1,000
Series B Preferred Stock [Member]
Balance	$ 125	$ 96
Balance, shares	125,001	96,429
Preferred stock issued as compensation for financing		$ 29
Preferred stock issued as compensation for financing, shares		28,572
Series B Preferred stock dividend
Deemed distributions to CEO
Net Loss
Balance	$ 125	$ 125
Balance, shares	125,001	125,001
Common Stock [Member]
Balance	$ 2,410	$ 2,410
Balance, shares	2,410,229	2,410,229
Preferred stock issued as compensation for financing
Preferred stock issued as compensation for financing, shares
Series B Preferred stock dividend
Deemed distributions to CEO
Net Loss
Balance	$ 2,410	$ 2,410
Balance, shares	2,410,229	2,410,229
Additional Paid-In Capital [Member]
Balance	$ 7,388,909	$ 6,893,176
Preferred stock issued as compensation for financing		399,971
Series B Preferred stock dividend	(9,986)	(9,986)
Deemed distributions to CEO		(155,694)
Net Loss
Balance	7,378,923	7,127,467
Accumulated Deficit [Member]
Balance	(11,030,550)	(6,905,767)
Preferred stock issued as compensation for financing
Series B Preferred stock dividend
Net Loss	(254,683)	(2,011,624)
Balance	(11,285,233)	(8,917,391)
Balance	(3,639,105)	(10,084)
Preferred stock issued as compensation for financing		400,000
Series B Preferred stock dividend	(9,986)	(9,986)
Deemed distributions to CEO		(155,694)
Net Loss	(254,683)	(2,011,624)
Balance	$ (3,903,774)	$ (1,787,388)

Consolidated Statements of Cash

Consolidated Statements of CashFlows (Unaudited) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Cash flows from Operating Activities:
Net loss	$ (254,683)	$ (2,011,624)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expenses	2,337	1,958
Interest expense on convertible notes
Initial recognition of loss of derivative liabilities		1,739,698
Interest expense accretion of convertible notes discount	91,222	99,330
Change in fair value of derivative liabilities	(129,065)	(37,994)
Non cash operating lease expense	39,386	39,387
Changes in Operating Assets and Liabilities:
Prepaid expense		(17,244)
Security Deposits		(66,155)
Due from related parties	11,374	(70,697)
Accounts payable and accrued expenses	185,443	(21,151)
Right of use liabilities	(29,998)	(25,482)
Net cash used in operating activities	(106,732)	(369,974)
Cash flows from Investing Activities:
Purchases of property and equipment		(66,378)
Net cash used in investing activities		(66,378)
Cash flows from Financing Activities:
Proceeds from notes payable	150,000
Proceeds from convertible notes	45,000	750,000
Net cash provided by financing activities	195,000	750,000
Net Change in Cash	88,268	313,648
Cash - Beginning of Reporting Period	1,915
Cash - End of Reporting Period	90,183	313,648	$ 1,915
Supplemental Disclosure of Cash Flow Information
Interest Paid
Income tax paid
Issuance of Series B preferred stock as compensation for deferred financing fees		400,000
Dividends declared on series B preferred stock	9,986	9,986
Right of use assets and right of use liabilities recognized		879,635
Initial recognition of debt discount		845,000
Deemed distribution to CEO		$ 155,694

Organization and Operations

Organization and Operations	3 Months Ended
	Mar. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Operations	Note 1 - Organization and Operations Bridgeway National Corp., which we refer to as “the Company,” “our Company,” “we,” “us” or “our,”‎ was originally incorporated under the laws of the State of Nevada as Snap Online Marketing Inc. on June 4, 2012 and subsequently changed its name to LifeLogger Technologies Corp., which we were referred to as “LifeLogger.” On April 10, 2019, we reincorporated as a Delaware corporation and changed our name to Capital Park Holdings Corp. On December 19, 2019, we changed our name to Bridgeway National Corp. Our principal business address is 1015 15 th Corporate Structure The Company is structured as a Delaware corporation that we expect to be treated as a corporation for U.S. federal income tax purposes. Your rights as a holder of shares, and the fiduciary duties of the Company’s Board of Directors and executive officers, and any limitations relating thereto are set forth in the documents governing the Company and may differ from those applying to a Delaware corporation. However, the documents governing the Company specify that the duties of its directors and officers will be generally consistent with the duties of a director of a Delaware corporation. The Company’s Board of Directors will oversee the management of the Company and our businesses. Initially, the Company’s Board of Directors will be comprised of five (5) directors, with three (3) of those directors appointed by holders of the Company’s Class A common stock and two (2) of those directors appointed by holders of the Company’s Class B common stock, and at least three (3) of whom will be the Company’s independent directors. Prior to the transactions that took place on January 9, 2019, we were a lifelogging software company that developed and hosted a proprietary cloud-based software solution ‎accessible on iOS and Android devices that offers an enhanced media experience for consumers by augmenting ‎videos, livestreams and photos with additional context information and providing a platform that makes it easy to ‎find and use that data when viewing or sharing media. Subsequent to transactions that took place on January 9, 2019, in addition to its lifelogging software business, the Company has been structured as a holding company ‎with a business strategy focused on owning subsidiaries engaged in a number of diverse business activities.‎

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 - Summary of Significant Accounting Policies Reclassification Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements. These reclassifications had no effect on the previously reported net loss. Liquidity and Basis of Presentation The accompanying unaudited consolidated financial statements are expressed in United States dollars (“USD”) and related Notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited consolidated financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to present a fair statement of the results for the interim periods presented. Unaudited interim results are not necessarily indicative of the results for the full fiscal year. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company for the year ended December 31, 2020 and notes thereto contained in the information as part of the Company’s Annual Report on Form 10-K, which was filed with the Securities and Exchange Commission on June 1, 2021. The unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. As reflected in the unaudited consolidated financial statements, the Company had an accumulated deficit of $11,285,233 at March 31, 2021, and a net loss of $254,683 for the three-month ended March 31,2021. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Although the Company has recently broadened its business and operating model in an effort to generate more sufficient and stable sources of revenues and cash flows, its cash position is not sufficient to support its daily operations. While the Company believes that its new business and operating model presents a viable strategy to generate sufficient revenue and believes in its ability to raise additional funds by way of a public or private offering, there can be no assurances to that effect. The unaudited consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary if the Company is unable to continue as a going concern.

Notes Payable and Convertible N

Notes Payable and Convertible Notes Payable	3 Months Ended
	Mar. 31, 2021
Debt Disclosure [Abstract]
Notes Payable and Convertible Notes Payable	Note 3 – Notes Payable and Convertible Notes Payable Convertible Notes Issue Date Interest March 31, 2021 Principal March 2, 2020 12 % $ 845,000 September 30, 2020 6 % $ 155,000 October 3, 2020 6 % $ 155,000 October 23, 2020 9 % $ 68,000 November 16, 2020 9 % $ 48,000 January 20, 2021 9 % $ 48,000 Total $ 1,319,000 The weighted average interest rate and remaining term of the fixed rate convertible notes payable is 10% and 4.74 months as of March 31, 2021. Notes Payable Issue Date Interest March 31, 2021 Principal March 24, 2021 3.75 % $ 150,000 Total $ 150,000 The movement in notes payable and convertible notes payable is as follows: Original Amount Unamortized Discount Guaranteed Interest Accrued Total Issued: March 2, 2020 (ii) 845,000 - 142,368 $ 987,368 Issued: September 30, 2020 (ii) 155,000 (37,917 ) 4,612 $ 121,695 Issued October 3, 2020 (ii) 155,000 (52,241 ) 4,612 $ 107,371 Issued: October 23, 2020 (iii) 68,000 (1,693 ) 2,210 $ 68,517 Issued: November 16, 2020 (iii) 48,000 (1,890 ) 2,025 $ 48,135 Issued: January 20, 2021 (iii) 48,000 (2,425 ) 1,053 $ 46,628 Issued: March 24, 2021 (iv) 150,000 - - $ 150,000 Ending as of March 31,2021 $ 1,469,000 (96,166 ) 156,880 $ 1,529,714 (i) Securities Purchase Agreement and Convertible Notes Issued to Calvary Fund I, LP; Oasis Capital, LLC and SBI Investments LLC On March 2, 2020 (the “Issue Date”), the Company entered into an unsecured promissory note purchase agreement with SBI, on behalf of itself and the other note purchasers (the “Note Purchasers”), pursuant to which the Note Purchasers purchased from the Company (a) 12% convertible promissory notes of the Company in an aggregate principal amount of $845,000 (the “12% Notes”) of which $75,000 were related to original issuance discount and $20,000 were related to deferred finance costs (with the understanding that the initial six months of such interest shall be guaranteed) (together with any note(s) issued in replacement thereof or as a dividend thereon or otherwise with respect thereto in accordance with the terms thereof, the “Notes”, and each, a “Note”), convertible into shares (the “Conversion Shares”) of common stock of the Company (the “Common Stock”) and (b) warrants (the “Warrants”) to acquire up to 1,111,842 Shares subject to a beneficial ownership cap of no greater than 4.99% in the case of each Purchaser (the “Warrant Shares”). The maturity date of the 12% Notes shall be on that day that is nine (9) months after the Issue Date (the “Maturity Date”) and is the date upon which the principal amount of the 12% Notes, as well as all accrued and unpaid interest and other fees, shall be due and payable. The notes are currently in Default status at a rate of 24% which has been accrued. As at March 31, 2021 the Company owed $845,000 in principal and the accrued interest was $142,368, which consisted of accrued interest and default interest. (ii) On September 30, 2020 (the “Issue Date”), the Company entered into an unsecured promissory note purchase agreement with SBI, on behalf of itself and the other note purchasers (the “Note Purchasers”), pursuant to which the Note Purchasers purchased from the Company (a) two 6% convertible promissory notes ($155,000 each) of the Company in an aggregate principal amount of $310,000 (the “6% Notes”) convertible into Shares (the “Conversion Shares”) subject to a beneficial ownership cap of no greater than 4.99% in the case of each Purchaser. Pursuant to the agreement, each note was issued with an original issue discount of $5,000 and as such the purchase price was $150,000. The proceeds of one note was received on October 3, 2020. The maturity date of the 6% Notes shall be on that day that is nine (9) months after the Issue Date (the “Maturity Date”) and is the date upon which the principal amount of the 6% Notes, as well as all accrued and unpaid interest and other fees, shall be due and payable. The notes also carry a default rate of 18%. As at March 31, 2021 the Company owed $310,000 in principal and the accrued interest was $9,224. The debenture is convertible into common shares of the Company at a conversion price $0.16. The convertible debt was not considered tainted due to 5,812,500 shares of common stock held on reserve for issuance upon full conversion of this debenture. The Company evaluated the convertible notes for a beneficial conversion feature in accordance with ASC 470-20 “Debt with Conversion and Other Options.” The Company determined that the conversion price was below the closing stock price on the commitment date, and the convertible notes contained a beneficial conversion feature. The Company recognized the intrinsic value of the embedded beneficial conversion feature of $258,750 as additional paid-in capital and reduced the carrying value of the convertible notes to $41,250. The carrying value will be accreted over the term of the convertible notes up to their face value of $310,000. As at March 31, 2021, the carrying value of the 6% Note was $219,842 and had an unamortized discount of $90,158 ($86,806 beneficial conversion feature and $3,352 OID). (iii) Securities Purchase Agreement and Convertible Notes Issued to Geneva Roth Remark Holdings, Inc. On October 23, 2020 (the “Issue Date”), the Company entered into an unsecured promissory note purchase agreement with Geneva Roth Remark Holdings, Inc. (the “Note Purchaser”), pursuant to which the Note Purchaser purchased from the Company (a) the 9% convertible promissory note of the Company in an aggregate principal amount of $68,000 ($3,000 OID) (the “9% Note”) convertible into Shares (the “Conversion Shares”) subject to a beneficial ownership cap of no greater than 4.99% in the case of the Purchaser (the “Maximum Share Amount”). The maturity date of the 9% Note shall be on October 23, 2021 (the “Maturity Date”) and is the date upon which the principal amount of the 9% Note, as well as all accrued and unpaid interest and other fees, shall be due and payable. The Note also has a 22% default interest rate. The “Conversion Price” shall be equal to the Variable Conversion Price (as defined below) (subject to equitable adjustments for stock splits, stock dividends or rights offerings by the Company relating to the Company’s securities or the securities of any subsidiary of the Company, combinations, recapitalization, reclassifications, extraordinary distributions and similar events). The “Variable Conversion Price” shall mean 65% multiplied by the Market Price (as defined below) (representing a discount rate of 35%). “Market Price” means the average of the three (3) lowest trading prices) for the shares during the fifteen (15) trading day period ending on the latest complete trading day prior to the Conversion Date As at March 31, 2021 the Company owed $68,000 in principal and the accrued interest was $2,210 with unamortized debt discount of $1,693. On November 16, 2020 (the “Issue Date”), the Company entered into an unsecured promissory note purchase agreement with Geneva Roth Remark Holdings, Inc. (the “Note Purchaser”), pursuant to which the Note Purchaser purchased from the Company (a) the 9% convertible promissory note of the Company in an aggregate principal amount of $48,000 ($3,000 OID) (the “9% Note II”) convertible into Shares (the “Conversion Shares”) subject to a beneficial ownership cap of no greater than 4.99% in the case of the Purchaser (the “Maximum share Amount”). The maturity date of the 9% Note II shall be on November 16, 2021 (the “Maturity Date”) and is the date upon which the principal amount of the 9% Note, as well as all accrued and unpaid interest and other fees, shall be due and payable. The Note also has a 22% default interest rate. The “Conversion Price” shall be equal to the Variable Conversion Price (as defined below) (subject to equitable adjustments for stock splits, stock dividends or rights offerings by the Company relating to the Company’s securities or the securities of any subsidiary of the Company, combinations, recapitalization, reclassifications, extraordinary distributions and similar events). The “Variable Conversion Price” shall mean 65% multiplied by the Market Price (as defined below) (representing a discount rate of 35%). “Market Price” means the average of the three (3) lowest trading prices) for the shares during the fifteen (15) trading day period ending on the latest complete trading day prior to the Conversion Date As at March 31, 2021 the Company owed $48,000 in principal and the accrued interest was $2,025 with unamortized debt discount of $1,890. On January 20, 2021 (the “Issue Date”), the Company entered into an unsecured promissory note purchase agreement with Geneva Roth Remark Holdings, Inc. (the “Note Purchaser”), pursuant to which the Note Purchaser purchased from the Company (a) the 9% convertible promissory note of the Company in an aggregate principal amount of $48,000 ($3,000 OID) (the “9% Note III”) convertible into Shares (the “Conversion Shares”) subject to a beneficial ownership cap of no greater than 4.99% in the case of the Purchaser (the “Maximum share Amount”). The maturity date of the 9% Note III shall be on January 20, 2022 (the “Maturity Date”) and is the date upon which the principal amount of the 9% Note, as well as all accrued and unpaid interest and other fees, shall be due and payable. The Note also has a 22% default interest rate. The “Conversion Price” shall be equal to the Variable Conversion Price (as defined below) (subject to equitable adjustments for stock splits, stock dividends or rights offerings by the Company relating to the Company’s securities or the securities of any subsidiary of the Company, combinations, recapitalization, reclassifications, extraordinary distributions and similar events). The “Variable Conversion Price” shall mean 65% multiplied by the Market Price (as defined below) (representing a discount rate of 35%). “Market Price” means the average of the three (3) lowest trading prices) for the shares during the fifteen (15) trading day period ending on the latest complete trading day prior to the Conversion Date As at March 31, 2021 the Company owed $48,000 in principal and the accrued interest was $1,053 with unamortized debt discount of $2,425. (iv) Notes issued to the Small Business Administration On March 24, 2021, Bridgeway was approved for a SBA Loan-2 in the amount of $150,000. SBA Loan-2, interest will accrue at the rate of 3.75% per annum with installment payments, including principal and interest, of $731.00 per month beginning on the twelve (12) month anniversary of the funding date. The balance of principal and interest will be payable on the thirty (30) year anniversary of the funding date.

Derivative Liability

Derivative Liability	3 Months Ended
	Mar. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liability	Note 4 – Derivative Liability In connection with the sale of debt or equity instruments, the Company may sell warrants to purchase the Company’s common stock. In certain circumstances, these warrants may be classified as derivative liabilities, rather than as equity. Additionally, the debt or equity instruments may contain embedded derivative instruments, such as embedded derivative features which in certain circumstances may be required to be bifurcated from the associated host instrument and accounted for separately as a derivative instrument liability. The Company’s derivative instrument liabilities are re-valued at the end of each reporting period, with changes in the fair value of the derivative liability recorded as charges or credits to income in the period in which the changes occur. For warrants and bifurcated embedded derivative features that are accounted for as derivative instrument liabilities, the Company estimates fair value using either quoted market prices of financial instruments with similar characteristics or other valuation techniques. The valuation techniques require assumptions related to the remaining term of the instruments and risk-free rates of return, the Company’s current common stock price and expected dividend yield, and the expected volatility of the Company’s common stock price over the life of the instrument. The following table summarizes the warrant derivative liabilities and convertible notes activity for the three months ended March 31, 2021: Derivative Liabilities Derivative liabilities as at December 31, 2020 $ 1,717,337 Change in fair value of warrants and notes (129,065 ) Derivative liabilities as at March 31, 2021 $ 1,588,272 The Monte Carlo methodology was used to value the derivative components, using the following assumptions: Warrants Notes Dividend yield - 12 % Risk-free rate for term 0.35 % 0.03 % Volatility 342.3 % 393.9 % Remaining term (Years) 3.92 0.25 Stock Price $ 0.0373 $ 0.0373

Fair Value of Financial Instrum

Fair Value of Financial Instruments	3 Months Ended
	Mar. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Note 5 – Fair Value of Financial Instruments The Company’s financial instruments consist of cash and cash equivalents, accounts payable and accrued expenses, derivative liabilities and convertible debt. The estimated fair value of the financial instruments approximate their carrying amounts due to the short-term nature of these instruments. The Company utilizes various types of financing to fund its business needs, including convertible debt with warrants attached. The Company reviews its warrants and conversion features of securities issued as to whether they are freestanding or contain an embedded derivative and, if so, whether they are classified as a liability at each reporting period until the amount is settled and reclassified into equity with changes in fair value recognized in current earnings. The fair value of the warrants and the embedded conversion feature of the convertible debt is classified as a liability. Some of these units have embedded conversion features that are treated as a discount on the convertible notes. Such financial instruments are initially recorded at fair value and amortized to interest expense over the life of the debt using the effective interest method. Inputs used in the valuation to derive fair value are classified based on a fair value hierarchy which distinguishes between assumptions based on market data (observable inputs) and an entity’s own assumptions (unobservable inputs). The hierarchy consists of three levels: Level one - Quoted market prices in active markets for identical assets or liabilities; Level two - Inputs other than level one inputs that are either directly or indirectly observable; and Level three - Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use. Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each quarter. The Company’s derivative liability is measured at fair value on a recurring basis. The Company classifies the fair value of these convertible notes and warrants derivative liability under level three. The Company’s settlement payable is measured at fair value on a recurring basis based on the most recent settlement offer. The Company classifies the fair value of the settlement payable under level three. The Company’s rescission liability is measured at fair value on a recurring basis based on the most recent stock price. The Company classifies the fair value of the rescission liability under level one. Based on ASC Topic 815 and related guidance, the Company concluded the common stock purchase warrants are required to be accounted for as derivatives as of the issue date due to a reset feature on the exercise price. At the date of issuance warrant derivative liabilities were measured at fair value using either quoted market prices of financial instruments with similar characteristics or other valuation techniques. The Company records the fair value of these derivatives on its balance sheet at fair value with changes in the values of these derivatives reflected in the consolidated statements of operations as “Change in fair value of derivative liabilities” These derivative instruments are not designated as hedging instruments under ASC 815-10 and are disclosed on the balance sheet under Derivative Liabilities. The following table presents liabilities that are measured and recognized at fair value on a recurring and non-recurring basis: Description Level 1 Level 2 Level 3 Derivatives $ - $ - $ 1,717,337 Fair Value at December 31, 2020 $ - $ - $ 1,717,337 Derivatives $ - $ - $ 1,588,272 Fair Value at March 31, 2021 $ - $ - $ 1,588,272

Stock Options and Warrants

Stock Options and Warrants	3 Months Ended
	Mar. 31, 2021
Share-based Payment Arrangement [Abstract]
Stock Options and Warrants	Note 6 – Stock Options and Warrants: As at March 31, 2021, the Company had the following warrant securities outstanding: Common Stock Warrants December 31, 2020 2,640,625 * Less: Exercised - Less: Cancelled - Add: Issued March 31, 2021 2,640,625 Warrants (Note 3) 1,111,842 Exercise Price $ 0.380 Expiration Date March 2, 2025 The fair value of the warrants at issuance was $577,868, with an expiration of March 2, 2025 and exercise price of $0.380. During the year ended December 31, 2020, the exercise price was reset to $0.16. The fair value of the warrants as at March 31, 2021 was $473,759.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Note 7 – Related Party Transactions During the three months ended March 31, 2021, an amount of $11,374 in payments were made to the CEO. Included the due to related party balance sheet account was a balance of $69,903 owing to the current CEO of the Company as of March 31, 2021, which were unsecured, bore no interest and were due on demand.

Stockholders' Deficiency

Stockholders' Deficiency	3 Months Ended
	Mar. 31, 2021
Equity [Abstract]
Stockholders' Deficiency	Note 8- Stockholders’ Deficiency Class A and Class B Common Stock Reverse Stock Split On October 16, 2020, the board of directors (the “Board”) of the Company and a stockholder holding a majority of the voting power of the Company’s voting stock (the “Majority Stockholder”) took action by joint written consent in lieu of a meeting to: (i) ratify the approval of an amendment to the Company’s certificate of incorporation, which amendment was filed with the Delaware Secretary of State on December 19, 2019 and was declared effective on January 20, 2020 (the “December 2019 Amendment”), which (i) changed the Company’s name from “Capital Park Holdings Corp.” to “Bridgeway National Corp.” and (ii) increased our authorized capital stock from 30,000,000 shares to 250,000,000 shares, of which 168,750,000 shares were designated as Class A Common Stock (the “Class A Common Stock”), 18,750,000 shares were designated as Class B Common Stock (the “Class B Common Stock”) and 62,500,000 shares were designated as preferred stock, of which 62,374,819 shares were previously designated as Series A Preferred Stock (the “Series A Preferred Stock”) and 125,181 shares were previously designated as Series B Preferred Stock (the “Series B Preferred Stock”); (ii) approve a further amendment to the Company’s certificate of incorporation (the “Recapitalization Amendment”) to increase the Common Stock from 187,500,000 shares to 400,000,000 shares, of which 360,000,000 shares will be designated as the Class A Common Stock and 40,000,000 shares will be designated as the Class B Common Stock and (iii) approve an additional amendment to the certificate of incorporation to effect a reverse stock split of our outstanding shares of our Class A Common Stock and Class B Common Stock at the at the ratio of one-for-4 (the “Reverse Stock Split Amendment,” and together with the December 2019 Amendment and the Recapitalization Amendment, collectively, the “Amendments”). The December 2019 Amendment will not be deemed ratified, and the Recapitalization Amendment and Reverse Stock Split Amendment will not be made effective until at least twenty (20) calendar days after the mailing of the Information Statement accompanying this Notice. In addition, the Reverse Stock Split Amendment will not be made effective until the Recapitalization Amendment is made effective and we receive FINRA approval for the Reverse Stock Split from the Financial Industry Regulatory Authority (“FINRA”). We received written notification that FINRA had approved the Reverse Stock Split on February 17, 2021. Preferred Stock During the three-month period ended March 31,2021, the Company declared $9,986 in dividends on the Series B Preferred Stock, of which $9,986 was accrued as a dividend payable.

Lease

Lease	3 Months Ended
	Mar. 31, 2021
Leases [Abstract]
Lease	Note 9- Lease The Company entered into an operating lease agreement with a scheduled commencement date on January 15, 2020 for a sixty-seven-month term, with an option to renew for a five-year term. The Company adopted ASC 842 – Leases using the modified retrospective cumulative catch-up approach beginning on January 1, 2019. Under this approach, the Company did not restate its comparative amounts and recognized a right-of-use asset equal to the present value of the future lease payments. The Company elected to apply the practical expedient to only transition contracts which were previously identified as leases and elected to not recognize right-of-use assets and lease obligations for leases of low value assets. When measuring the right of use liabilities, the Company discounted lease payments using its incremental borrowing rate at January 15, 2020. The weighted-average-rate applied is 12%. $ Operating lease right-of-use asset at December 31, 2020 722,088 Amortization (39,386 ) Balance at March 31, 2021 682,702 Right of use liabilities – operating leases at December 31, 2020 773,004 Principal repayment (29,998 ) Balance at March 31, 2021 743,006 Current portion of right of use liabilities – operating leases 130,644 Noncurrent portion of right of use liabilities – operating leases 612,362 The operating lease expense was $52,779 for the three months ended March 31, 2021 and included in the general and administrative expenses. The following table represents the contractual undiscounted cash flows for right of use liabilities – operating leases due within twelve months of March 31,2021 $ 2021 158,336 2022 216,392 2023 221,802 2024 227,347 2025 135,934 Total minimum lease payments 959,811 Less: effect of discounting (216,805 ) Present value of future minimum lease payments 743,006 Less: current portion of right of use liabilities – operating leases 130,644 Noncurrent portion of right of use liabilities – operating leases 612,362

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2021
Subsequent Events [Abstract]
Subsequent Events	Note 10- Subsequent Events On March 31, 2021, Bridgeway was approved for a SBA Loan-1 in the amount of $723,743. SBA Loan-1 shall be eligible for forgiveness if during the 8-to-24-week covered period following disbursement: (i) employee and compensation levels are maintained; (ii) the loan proceeds are spent on payroll costs and other eligible expenses and (iii) at least 60% of the proceeds are spent on payroll costs. For any portion of the SBA Loan-1 that is not forgiven, it will bear interest at a 1% fixed APR for the life of the loan with payments deferred for ten (10) months. Subsequent to the approval, cash was received as of April 2021.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Reclassification	Reclassification Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements. These reclassifications had no effect on the previously reported net loss.
Liquidity and Basis of Presentation	Liquidity and Basis of Presentation The accompanying unaudited consolidated financial statements are expressed in United States dollars (“USD”) and related Notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited consolidated financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to present a fair statement of the results for the interim periods presented. Unaudited interim results are not necessarily indicative of the results for the full fiscal year. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company for the year ended December 31, 2020 and notes thereto contained in the information as part of the Company’s Annual Report on Form 10-K, which was filed with the Securities and Exchange Commission on June 1, 2021. The unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. As reflected in the unaudited consolidated financial statements, the Company had an accumulated deficit of $11,285,233 at March 31, 2021, and a net loss of $254,683 for the three-month ended March 31,2021. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Although the Company has recently broadened its business and operating model in an effort to generate more sufficient and stable sources of revenues and cash flows, its cash position is not sufficient to support its daily operations. While the Company believes that its new business and operating model presents a viable strategy to generate sufficient revenue and believes in its ability to raise additional funds by way of a public or private offering, there can be no assurances to that effect. The unaudited consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary if the Company is unable to continue as a going concern.

Notes Payable and Convertible_2

Notes Payable and Convertible Notes Payable (Tables)	3 Months Ended
	Mar. 31, 2021
Debt Disclosure [Abstract]
Schedule of Convertible Notes Payable	Convertible Notes Issue Date Interest March 31, 2021 Principal March 2, 2020 12 % $ 845,000 September 30, 2020 6 % $ 155,000 October 3, 2020 6 % $ 155,000 October 23, 2020 9 % $ 68,000 November 16, 2020 9 % $ 48,000 January 20, 2021 9 % $ 48,000 Total $ 1,319,000
Schedule of Long-term Notes Payable	The weighted average interest rate and remaining term of the fixed rate convertible notes payable is 10% and 4.74 months as of March 31, 2021. Notes Payable Issue Date Interest March 31, 2021 Principal March 24, 2021 3.75 % $ 150,000 Total $ 150,000
Schedule of Movement in Notes Payable and Convertible Notes Payable	The movement in notes payable and convertible notes payable is as follows: Original Amount Unamortized Discount Guaranteed Interest Accrued Total Issued: March 2, 2020 (ii) 845,000 - 142,368 $ 987,368 Issued: September 30, 2020 (ii) 155,000 (37,917 ) 4,612 $ 121,695 Issued October 3, 2020 (ii) 155,000 (52,241 ) 4,612 $ 107,371 Issued: October 23, 2020 (iii) 68,000 (1,693 ) 2,210 $ 68,517 Issued: November 16, 2020 (iii) 48,000 (1,890 ) 2,025 $ 48,135 Issued: January 20, 2021 (iii) 48,000 (2,425 ) 1,053 $ 46,628 Issued: March 24, 2021 (iv) 150,000 - - $ 150,000 Ending as of March 31,2021 $ 1,469,000 (96,166 ) 156,880 $ 1,529,714

Derivative Liability (Tables)

Derivative Liability (Tables)	3 Months Ended
	Mar. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Summary of Warrants Derivative Liabilities Activity	The following table summarizes the warrant derivative liabilities and convertible notes activity for the three months ended March 31, 2021: Derivative Liabilities Derivative liabilities as at December 31, 2020 $ 1,717,337 Change in fair value of warrants and notes (129,065 ) Derivative liabilities as at March 31, 2021 $ 1,588,272
Schedule of Warrants Issued with Assumptions	The Monte Carlo methodology was used to value the derivative components, using the following assumptions: Warrants Notes Dividend yield - 12 % Risk-free rate for term 0.35 % 0.03 % Volatility 342.3 % 393.9 % Remaining term (Years) 3.92 0.25 Stock Price $ 0.0373 $ 0.0373

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2021
Fair Value Disclosures [Abstract]
Schedule of Fair Value of Liabilities	The following table presents liabilities that are measured and recognized at fair value on a recurring and non-recurring basis: Description Level 1 Level 2 Level 3 Derivatives $ - $ - $ 1,717,337 Fair Value at December 31, 2020 $ - $ - $ 1,717,337 Derivatives $ - $ - $ 1,588,272 Fair Value at March 31, 2021 $ - $ - $ 1,588,272

Stock Options and Warrants (Tab

Stock Options and Warrants (Tables)	3 Months Ended
	Mar. 31, 2021
Share-based Payment Arrangement [Abstract]
Schedule of Warrant Outstanding	As at March 31, 2021, the Company had the following warrant securities outstanding: Common Stock Warrants December 31, 2020 2,640,625 * Less: Exercised - Less: Cancelled - Add: Issued March 31, 2021 2,640,625 Warrants (Note 3) 1,111,842 Exercise Price $ 0.380 Expiration Date March 2, 2025

Lease (Tables)

Lease (Tables)	3 Months Ended
	Mar. 31, 2021
Leases [Abstract]
Schedule of Lease Obligations	$ Operating lease right-of-use asset at December 31, 2020 722,088 Amortization (39,386 ) Balance at March 31, 2021 682,702 Right of use liabilities – operating leases at December 31, 2020 773,004 Principal repayment (29,998 ) Balance at March 31, 2021 743,006 Current portion of right of use liabilities – operating leases 130,644 Noncurrent portion of right of use liabilities – operating leases 612,362
Schedule of Contractual Undiscounted Cash Flows	The following table represents the contractual undiscounted cash flows for right of use liabilities – operating leases due within twelve months of March 31,2021 $ 2021 158,336 2022 216,392 2023 221,802 2024 227,347 2025 135,934 Total minimum lease payments 959,811 Less: effect of discounting (216,805 ) Present value of future minimum lease payments 743,006 Less: current portion of right of use liabilities – operating leases 130,644 Noncurrent portion of right of use liabilities – operating leases 612,362

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Accounting Policies [Abstract]
Accumulated deficit	$ (11,285,233)		$ (11,030,550)
Net loss	$ (254,683)	$ (2,011,624)

Notes Payable and Convertible_3

Notes Payable and Convertible Notes Payable (Details Narrative) - USD ($)	Mar. 24, 2021	Jan. 20, 2021	Nov. 16, 2020	Oct. 23, 2020	Sep. 30, 2020	Mar. 02, 2020	Mar. 31, 2021	Mar. 31, 2020
Debt, term							4 years 8 months 26 days
Debt interest rate							10.00%
Debt principal amount							$ 1,319,000
Purchase price of notes payable							150,000
Beneficial conversion feature on convertible preferred stock
SBA Loan - 2 [Member]
Debt interest rate	3.75%
Debt principal amount	$ 150,000
Monthly payment	$ 731
Purchase Agreement [Member] | 12% Notes [Member]
Debt interest rate						12.00%
Debt principal amount						$ 845,000	845,000
Debt instrument unamortized discount						75,000
Deferred finance costs						$ 20,000
Acquisition of warrant shares						1,111,842
Maturity date description						The maturity date of the 12% Notes shall be on that day that is nine (9) months after the Issue Date (the "Maturity Date") and is the date upon which the principal amount of the 12% Notes, as well as all accrued and unpaid interest and other fees, shall be due and payable. The notes are currently in Default status at a rate of 24% which has been accrued.
Accrued interest							142,368
Purchase Agreement [Member] | 12% Notes [Member] | Minimum [Member]
Beneficial ownership percentage						4.99%
Purchase Agreement [Member] | 6% Notes One [Member]
Debt interest rate					6.00%
Debt principal amount					$ 155,000
Purchase Agreement [Member] | 6% Notes Two [Member]
Debt interest rate					6.00%
Debt principal amount					$ 155,000
Purchase Agreement [Member] | 6% Notes [Member]
Debt interest rate					6.00%
Debt principal amount					$ 310,000		310,000
Debt instrument unamortized discount					$ 5,000		$ 90,158
Maturity date description					The maturity date of the 6% Notes shall be on that day that is nine (9) months after the Issue Date (the "Maturity Date") and is the date upon which the principal amount of the 6% Notes, as well as all accrued and unpaid interest and other fees, shall be due and payable. The notes also carry a default rate of 18%.
Conversion description							The debenture is convertible into common shares of the Company at a conversion price $0.04. The convertible debt was not considered tainted due to 5,812,500 shares of common stock held on reserve for issuance upon full conversion of this debenture. The Company evaluated the convertible notes for a beneficial conversion feature in accordance with 0ASC 470-20 "Debt with Conversion and Other Options." The Company determined that the conversion price was below the closing stock price on the commitment date, and the convertible notes contained a beneficial conversion feature. The Company recognized the intrinsic value of the embedded beneficial conversion feature of $258,750 as additional paid-in capital and reduced the carrying value of the convertible notes to $41,250. The carrying value will be accreted over the term of the convertible notes up to their face value of $310,000.
Orginal issue discount							$ 3,352
Accrued interest							$ 9,224
Purchase price of notes payable					$ 150,000
Conversion price per share							$ 0.16
Beneficial conversion feature on convertible preferred stock							$ 258,750
Convertible debt							41,250
Debt beneficial conversion feature							86,806
Debt instrument carrying value							219,842
Purchase Agreement [Member] | 9% Notes [Member]
Debt interest rate				9.00%
Debt principal amount				$ 68,000			68,000
Debt instrument unamortized discount							1,693
Conversion description				The "Variable Conversion Price" shall mean 65% multiplied by the Market Price (as defined below) (representing a discount rate of 35%). "Market Price" means the average of the three (3) lowest trading prices) for the shares during the fifteen (15) trading day period ending on the latest complete trading day prior to the Conversion Date
Accrued interest							2,210
Debt default interest rate				22.00%
Purchase Agreement [Member] | 9% Notes [Member] | Maximum [Member]
Beneficial ownership percentage				4.99%
Purchase Agreement [Member] | 9% Notes II [Member]
Debt interest rate			9.00%
Debt principal amount			$ 48,000				48,000
Debt instrument unamortized discount							1,890
Maturity date description			The maturity date of the 9% Note II shall be on November 16, 2021 (the "Maturity Date") and is the date upon which the principal amount of the 9% Note, as well as all accrued and unpaid interest and other fees, shall be due and payable. The Note also has a 22% default interest rate.
Conversion description			The "Variable Conversion Price" shall mean 65% multiplied by the Market Price (as defined below) (representing a discount rate of 35%). "Market Price" means the average of the three (3) lowest trading prices) for the shares during the fifteen (15) trading day period ending on the latest complete trading day prior to the Conversion Date
Orginal issue discount			$ 3,000
Accrued interest							2,025
Debt default interest rate			22.00%
Purchase Agreement [Member] | 9% Notes II [Member] | Maximum [Member]
Beneficial ownership percentage			4.99%
Unsecured Promissory Note Purchase Agreement [Member] | 9% Notes III [Member]
Debt principal amount		$ 48,000					48,000
Debt instrument unamortized discount							2,425
Maturity date description		The maturity date of the 9% Note III shall be on January 20, 2022 (the "Maturity Date") and is the date upon which the principal amount of the 9% Note, as well as all accrued and unpaid interest and other fees, shall be due and payable. The Note also has a 22% default interest rate.
Conversion description		The "Variable Conversion Price" shall mean 65% multiplied by the Market Price (as defined below) (representing a discount rate of 35%). "Market Price" means the average of the three (3) lowest trading prices) for the shares during the fifteen (15) trading day period ending on the latest complete trading day prior to the Conversion Date
Orginal issue discount		$ 3,000
Accrued interest							$ 1,053
Unsecured Promissory Note Purchase Agreement [Member] | 9% Notes III [Member] | Maximum [Member]
Beneficial ownership percentage		4.99%

Notes Payable and Convertible_4

Notes Payable and Convertible Notes Payable - Schedule of Convertible Notes Payable (Details)	3 Months Ended
	Mar. 31, 2021USD ($)
Interest Rate	10.00%
Principal Balance	$ 1,319,000
Convertible Notes Payable One [Member]
Note Issue Date	Mar. 2, 2020
Interest Rate	12.00%
Principal Balance	$ 845,000
Convertible Notes Payable Two [Member]
Note Issue Date	Sep. 30, 2020
Interest Rate	6.00%
Principal Balance	$ 155,000
Convertible Notes Payable Three [Member]
Note Issue Date	Oct. 3, 2020
Interest Rate	6.00%
Principal Balance	$ 155,000
Convertible Notes Payable Four [Member]
Note Issue Date	Oct. 23, 2020
Interest Rate	9.00%
Principal Balance	$ 68,000
Convertible Notes Payable Five [Member]
Note Issue Date	Nov. 16, 2020
Interest Rate	9.00%
Principal Balance	$ 48,000
Convertible Notes Payable Six [Member]
Note Issue Date	Jan. 20, 2021
Interest Rate	9.00%
Principal Balance	$ 48,000

Notes Payable and Convertible_5

Notes Payable and Convertible Notes Payable - Schedule of Long-term Notes Payable (Details)	3 Months Ended
	Mar. 31, 2021USD ($)
Interest Rate	10.00%
Principal Balance	$ 1,319,000
Notes Payable One [Member]
Note Issue Date	Mar. 24, 2021
Interest Rate	3.75%
Principal Balance	$ 150,000
Notes Payable [Member]
Principal Balance	$ 150,000

Notes Payable and Convertible_6

Notes Payable and Convertible Notes Payable - Schedule of Movement in Convertible Notes Payable (Details)	3 Months Ended
	Mar. 31, 2021USD ($)
Issued: March 2, 2020 [Member]
Convertible notes payable, Original amount	$ 845,000
Convertible notes payable, Unamortized discount
Convertible notes payable, Guaranteed Interest Accrued	142,368
Convertible notes payable, Net Settlement
Convertible notes payable	987,368
Issued: September 30, 2020 [Member]
Convertible notes payable, Original amount	155,000
Convertible notes payable, Unamortized discount	(37,917)
Convertible notes payable, Guaranteed Interest Accrued	4,612
Convertible notes payable, Net Settlement
Convertible notes payable	121,695
Issued: October 3, 2020 [Member]
Convertible notes payable, Original amount	155,000
Convertible notes payable, Unamortized discount	(52,241)
Convertible notes payable, Guaranteed Interest Accrued	4,612
Convertible notes payable, Net Settlement
Convertible notes payable	107,371
Issued: October 23, 2020 [Member]
Convertible notes payable, Original amount	68,000
Convertible notes payable, Unamortized discount	(1,693)
Convertible notes payable, Guaranteed Interest Accrued	2,210
Convertible notes payable, Net Settlement
Convertible notes payable	68,517
Issued: November 16, 2020 [Member]
Convertible notes payable, Original amount	48,000
Convertible notes payable, Unamortized discount	(1,890)
Convertible notes payable, Guaranteed Interest Accrued	2,025
Convertible notes payable, Net Settlement
Convertible notes payable	48,135
Issued: January 20, 2021 [Member]
Convertible notes payable, Original amount	48,000
Convertible notes payable, Unamortized discount	(2,425)
Convertible notes payable, Guaranteed Interest Accrued	1,053
Convertible notes payable	46,628
Issued: March 24, 2021 [Member]
Convertible notes payable, Original amount	150,000
Convertible notes payable, Unamortized discount
Convertible notes payable, Guaranteed Interest Accrued
Convertible notes payable	150,000
Ending Balance [Member]
Convertible notes payable, Original amount	1,469,000
Convertible notes payable, Unamortized discount	(96,166)
Convertible notes payable, Guaranteed Interest Accrued	156,880
Convertible notes payable, Net Settlement
Convertible notes payable	$ 1,529,714

Derivative Liability - Summary

Derivative Liability - Summary of Warrants Derivative Liabilities Activity (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Change in fair value of warrants and notes	$ 129,065	$ 37,994
Warrant Derivative Liabilities [Member]
Derivative liabilities beginning	1,717,337
Change in fair value of warrants and notes	(129,065)
Derivative liabilities ending	$ 1,588,272

Derivative Liability - Schedule

Derivative Liability - Schedule of Warrants Issued with Assumptions (Details)	3 Months Ended
	Mar. 31, 2021$ / shares
Stock Price	$ 0.0373
Dividend Yield [Member]
Fair value assumptions, measurement input, percentages	12
Risk-free Rate for Term [Member]
Fair value assumptions, measurement input, percentages	0.03
Volatility [Member]
Fair value assumptions, measurement input, percentages	393.9
Remaining Term (Years) [Member]
Fair value assumptions, measurement input, term	2 months 30 days
Warrant Derivative Liabilities [Member]
Stock Price	$ 0.0373
Warrant Derivative Liabilities [Member] | Dividend Yield [Member]
Fair value assumptions, measurement input, percentages	0
Warrant Derivative Liabilities [Member] | Risk-free Rate for Term [Member]
Fair value assumptions, measurement input, percentages	0.35
Warrant Derivative Liabilities [Member] | Volatility [Member]
Fair value assumptions, measurement input, percentages	342.3
Warrant Derivative Liabilities [Member] | Remaining Term (Years) [Member]
Fair value assumptions, measurement input, term	3 years 11 months 1 day

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Schedule of Fair Value of Liabilities (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Change in fair value of derivative liabilities	$ 129,065	$ 37,994
Level 1 [Member]
Change in fair value of derivative liabilities
Level 1 [Member] | Derivative [Member]
Change in fair value of derivative liabilities
Level 2 [Member]
Change in fair value of derivative liabilities
Level 2 [Member] | Derivative [Member]
Change in fair value of derivative liabilities
Level 3 [Member]
Change in fair value of derivative liabilities	1,588,272		1,717,337
Level 3 [Member] | Derivative [Member]
Change in fair value of derivative liabilities	$ 1,588,272		$ 1,717,337

Stock Options and Warrants (Det

Stock Options and Warrants (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Share-based Payment Arrangement [Abstract]
Fair value of the warrants at issuance	$ 577,686
Warrants expiration period	Mar. 2, 2025
Warrant exercise price	$ 0.380
Exercise price reset		$ .16
Fair value of the warrants	$ 473,759

Stock Options and Warrants - Sc

Stock Options and Warrants - Schedule of Warrant Outstanding (Details)	3 Months Ended
	Mar. 31, 2021$ / sharesshares
Exercise Price | $ / shares	$ 0.380
Expiration date	Mar. 2, 2025
Common Stock Warrants [Member]
Warrant outstanding, beginning balance	2,640,625
Less: Exercised
Less: Cancelled
Add: Issued
Warrant outstanding, ending balance	2,640,625
Common Stock Warrants One [Member]
Warrants	1,111,842
Exercise Price | $ / shares	$ 0.380
Expiration date	Mar. 2, 2025

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - CEO [Member]	3 Months Ended
	Mar. 31, 2021USD ($)
Payments made to related party	$ 11,374
Due to related party	$ 69,903

Stockholders' Deficiency (Detai

Stockholders' Deficiency (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020	Oct. 16, 2020	Oct. 15, 2020
Authorized shares capital			250,000,000	30,000,000
Recapitalization Amendment [Member]
Authorized shares capital			400,000,000	187,500,000
Class A Common Stock [Member]
Common stock, shares designated			168,750,000
Class A Common Stock [Member] | Recapitalization Amendment [Member]
Common stock, shares designated			360,000,000
Class B Common Stock [Member]
Common stock, shares designated			18,750,000
Series A Preferred Stock [Member]
Designated shares			62,500,000
Preferred stock, previously designated of shares			62,374,819
Series B Preferred Stock [Member]
Preferred stock, previously designated of shares			125,181
Class B Common Stock [Member]
Common stock, shares designated	18,750,000	18,750,000
Class B Common Stock [Member] | Recapitalization Amendment [Member]
Common stock, shares designated			40,000,000
Series B Preferred Stock [Member]
Accrued dividend	$ 9,986
Dividend declared	$ 9,986

Lease (Details Narrative)

Lease (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2021	Jan. 15, 2020
Leases [Abstract]
Lease description	The Company entered into an operating lease agreement with a scheduled commencement date on January 15, 2020 for a sixty-seven-month term, with an option to renew for a five-year term.
Lease renewal term		5 years
Lease weighted-average-rate		12.00%
Operating lease expense	$ 52,779

Lease - Schedule of Lease Oblig

Lease - Schedule of Lease Obligations (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Operating lease right-of-use asset at December 31, 2020	$ 722,088
Amortization	(39,386)
Balance at March 31, 2021	682,702
Right of use liabilities - operating leases at December 31, 2020	773,004
Principal repayment	(29,998)
Balance at March 31, 2021	743,006
Current portion of right of use liabilities - operating leases	130,644	$ 115,547
Noncurrent portion of right of use liabilities - operating leases	$ 612,362	$ 657,457

Lease - Schedule of Contractual

Lease - Schedule of Contractual Undiscounted Cash Flows (Details) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Leases [Abstract]
2021	$ 158,336
2022	216,392
2023	221,802
2024	227,347
2025	135,934
Total minimum lease payments	959,811
Less: effect of discounting	(216,805)
Present value of future minimum lease payments	743,006	$ 773,004
Less: current portion of right of use liabilities - operating leases	130,644	115,547
Noncurrent portion of right of use liabilities - operating leases	$ 612,362	$ 657,457

Subsequent Events (Details Narr

Subsequent Events (Details Narrative)	Mar. 31, 2021USD ($)
Debt instrument face amount	$ 1,319,000
SBA Loan - 1 [Member]
Debt instrument face amount	$ 723,743
Debt instrument, description	SBA Loan-1 shall be eligible for forgiveness if during the 8-to-24-week covered period following disbursement: (i) employee and compensation levels are maintained; (ii) the loan proceeds are spent on payroll costs and other eligible expenses and (iii) at least 60% of the proceeds are spent on payroll costs. For any portion of the SBA Loan-1 that is not forgiven, it will bear interest at a 1% fixed APR for the life of the loan with payments deferred for ten (10) months.